Trial of Septra for Uncomplicated Skin Abscesses in Patients at Risk for Community Acquired Methicillin-Resistant Staphylococcus Aureus Infection
Completed · Not applicable · Has a placebo group
Conditions studied: Abscess, Methicillin-Resistant Staphylococcus Aureus Infection
In brief
Patients will be enrolled in a multi-center study (Wilford Hall Medical Center and Brooke Army Medical Center) to prospectively evaluate outcome after treatment for an uncomplicated skin abscess.
Key facts
- Study ID
- NCT00822692
- Run by
- 59th Medical Wing
- People needed
- 139
- Starts
- 2008-07-01
- Expected to finish
- 2009-06-01
- Last updated by the study team
- 2015-12-21
Who can join
Age: 18 and older, up to 65. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- All patients age 18-65 who present to the emergency department with a skin abscess that requires incision and drainage.
You may not qualify if…
- Patients with diabetes, HIV, cancer or other immunocompromised patients.
- Additionally, any patients who received antibiotics within one week of presentation or were hospitalized in previous month will be excluded to minimize potential confounding variables.
- Pregnant and breastfeeding patients will also be excluded due to possible safety concerns with antibiotic treatment.
- Patients with abscesses on head, face, perirectal, or periananal regions, abscesses with known tracks or fistulas to deeper structures, or abscesses requiring surgical drainage in an operating room are excluded.
- Finally, patients with sulfa allergy will be excluded.
Where it is running
- Wilford Hall Medical Center — Lackland Air Force Base, Texas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.